Canada’s misguided changes to drug regulation could expedite unproven drugs and divert funds from other healthcare needs
Canadian government proposes new Agile licensing framework to accelerate pre-market regulation of pharmaceutical products. While Health Minister Jean-Yves Duclos says this is part of the government’s strategy to give Canadians access to quality, affordable medicines, the policy is likely to cause more harm than good. Adopting Agile Licensing would allow companies to market drugs up … Read more